# Aragen Life Sciences

**Canonical:** https://apis.io/providers/aragen-life-sciences/  
**Website:** https://www.aragen.com  
**APIs profiled:** 0

Aragen Life Sciences provides contract research, development, and manufacturing services (CRDMO) for small and large molecule drug discovery and development. The company offers integrated solutions across chemistry, biology, analytical development, and GMP manufacturing, supporting clients from early discovery through commercial production. Their platform includes scientific expertise, global locations, and a resource hub for investors and partners.

## Kin Score — 9.9 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 9.9).

| Facet | Score |
|---|---|
| Discoverability | 58.9 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 21.1 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 13.7 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Aragen Life Sciences Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Contract Research, Drug Discovery, Manufacturing, Biotechnology

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/aragen-life-sciences/). Scores are computed from the provider's own public artifacts under a published rubric.
